APD恢复控制心脏组织出现心律失常与RyR2功能障碍
D'Artagnan Greene1, Yohannes Shiferaw1
1Department of Physics and Astronomy, California State University, Northridge, CA, USA.
The Journal of physiology
|November 4, 2025
概括
心脏RyR2通道中的分子缺陷可以通过改变释放引起心律失常. 计算模型揭示了两种不同的细胞机制,取决于亚细胞结构,延长动作潜力并触发脱极化后,导致同步的组织事件和导电阻塞.
科学领域:
- 心血管生理学心血管生理学
- 计算生物学 计算生物学
- 分子心脏病学分子心脏病学
背景情况:
- 心律不整与心脏诺丁受体 (RyR2) 的分子缺陷有关.
- 连接RyR2功能障碍与组织水平电气干扰的确切机制尚不清楚.
- 了解这些联系对于开发有针对性的心律失常疗法至关重要.
研究的目的:
- 调查RyR2分子缺陷与心律失常之间的联系.
- 开发一个集成RyR2门和心脏电传播的多尺度计算模型.
- 阐明 RyR2 相关心律失常背后的细胞和组织水平机制.
主要方法:
- 开发了心脏组织的多尺度计算模型.
- 集成的RyR2门的动态与电气传播.
- 模拟的释放及其对行动潜能持续时间 (APD) 和细胞内处理的影响.
- 分析了亚细胞结构 (t-管) 在心律失常过程中的作用.
- 研究了APD还原斜率对组织中细胞事件同步的影响.
主要成果:
- 增加RyR2开放概率会增加的释放,触发依赖于亚细胞结构的节律失常机制.
- 在具有密集的t管细胞中,泄漏的RyR2s放大火花招募,延长APD并导致早期的脱极化.
- 在缺乏t管的细胞中,泄漏的RyR2s启动再生波,也延长APD并导致早期的脱极化.
- 组织中细胞干扰的同步取决于APD恢复斜率;斜率> 1导致交替,导电阻塞和心律失常.
- APD还原斜率<1阻止同步,对组织电活动没有影响.
结论:
- 基于亚细胞结构的不同细胞处理异常,RyR2功能障碍会导致心律失常.
- APD还原曲线的斜率是细胞事件是否同步产生器官水平心律失常的关键决定因素.
- 这项研究提供了RyR2分子缺陷与器官规模心律不整的发展之间的机制联系.
相关概念视频
01:29Disturbances in Heart Rhythm
2.5K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.5K
01:28Mechanism of Cardiac Arrhythmias
1.6K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.6K
01:25Dysrhythmias VI: Management of Dysrhythmias
424
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
424
01:19Electrophysiology of Normal Cardiac Rhythm
8.7K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
8.7K
01:18Dysrhythmias IV: Characteristics of Bradyarrhythmias
487
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
487
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.4K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K